Dong-A ST Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1932-01-01
- Employees
- 1.6K
- Market Cap
- -
- Website
- http://www.donga-st.com
A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-07-30
- Last Posted Date
- 2014-09-30
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 520
- Registration Number
- NCT01912066
- Locations
- 🇰🇷
Inje University Busan Paik Hospital, Busan, Korea, Republic of
A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®
- First Posted Date
- 2013-03-29
- Last Posted Date
- 2021-04-15
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 93
- Registration Number
- NCT01820728
- Locations
- 🇰🇷
Seoul National University Hospital Institutional Review Board, Seoul, Korea, Republic of
A Study to Demonstrate the Efficacy and Safety of Motilitone®
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-03-25
- Last Posted Date
- 2015-01-27
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 389
- Registration Number
- NCT01817465
- Locations
- 🇰🇷
Ajou University Medical Center, Suwon, Korea, Republic of
A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-03-25
- Last Posted Date
- 2021-04-15
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 258
- Registration Number
- NCT01817556
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, IRB, Seoul, Korea, Republic of
Study of DA-9801 to Treat Diabetic Neuropathic Pain
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-03-19
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 128
- Registration Number
- NCT01813799
- Locations
- 🇰🇷
Chonbuk National University Hospital, Jeonju, Korea, Republic of
A Clinical Study to Assess the Efficacy and Safety of DA-3002
- First Posted Date
- 2013-03-19
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 58
- Registration Number
- NCT01813630
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature
- First Posted Date
- 2013-02-08
- Last Posted Date
- 2017-10-19
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 70
- Registration Number
- NCT01786902
A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-12-18
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 37
- Registration Number
- NCT01751919
- Locations
- 🇰🇷
Kyungpook National University, Daegu, Korea, Republic of
Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
- First Posted Date
- 2012-08-29
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 74
- Registration Number
- NCT01674855
- Locations
- 🇰🇷
Korea University GURO hospital, Seoul, Korea, Republic of
Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-08-22
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT01670357
- Locations
- 🇰🇷
Seoul St.Mary's hospital, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath